KCM
ORGS

Kennedy Capital Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Kennedy Capital Management’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,517
Closed -$37K – 629
2022
Q2 		$37K Sell
1,517
-434
-22% -$12.1K ﹤0.01% 599
2022
Q1 		$68K Buy
+1,951
New +$59.3K ﹤0.01% 595

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kennedy Capital Management's ORGS Position: Q3 2022 in Review

Kennedy Capital Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2022, closing a stake of 1,517 shares — an estimated $37K sold.

Kennedy Capital Management first reported a position in ORGS in Q1 2022 and held it in 2 quarters. The position peaked at $68K in Q1 2022. 22 funds tracked by Wall St. Rank hold ORGS as of Q3 2022.

  • Kennedy Capital Management reported no remaining Orgenesis Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Kennedy Capital Management sold 1,517 Orgenesis Inc. Common Stock shares in Q3 2022, an estimated $37K.
  • Kennedy Capital Management first reported a position in Orgenesis Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Kennedy Capital Management's Orgenesis Inc. Common Stock position peaked at $68K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2022.

Based on Kennedy Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.